The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-03
DOI
10.1038/s41401-020-0484-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocular mucins in dry eye disease
- (2019) Céline Portal et al. EXPERIMENTAL EYE RESEARCH
- Corrigendum to: TFOS DEWS II pathophysiology report. Ocul Surf (2017)15(3): 438-510
- (2019) Anthony J. Bron et al. Ocular Surface
- Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages
- (2018) Yu-xi Yan et al. ACTA PHARMACOLOGICA SINICA
- Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
- (2018) Raphaël Boursereau et al. BMC BIOLOGY
- Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study
- (2018) Hiroshi Nakatani et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice
- (2017) Qian Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TFOS DEWS II Tear Film Report
- (2017) Mark D.P. Willcox et al. Ocular Surface
- TFOS DEWS II Epidemiology Report
- (2017) Fiona Stapleton et al. Ocular Surface
- TFOS DEWS II Definition and Classification Report
- (2017) Jennifer P. Craig et al. Ocular Surface
- Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy
- (2015) Tian-tian Li et al. ACTA PHARMACOLOGICA SINICA
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation
- (2015) Yanwei Wu et al. Cellular & Molecular Immunology
- α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways
- (2015) Yusha Ru et al. Scientific Reports
- The ocular surface epithelial barrier and other mechanisms of mucosal protection
- (2013) Flavio Mantelli et al. Current Opinion in Allergy and Clinical Immunology
- Benzalkonium Chloride and Glaucoma
- (2013) Carol A. Rasmussen et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell
- (2013) Xin Li et al. PLoS One
- Dry Eye Disease
- (2012) William Stevenson ARCHIVES OF OPHTHALMOLOGY
- SM934 Treated Lupus-Prone NZB×NZW F1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development
- (2012) Li-Fei Hou et al. PLoS One
- Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
- (2011) Li-Fei Hou et al. ARTHRITIS AND RHEUMATISM
- Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
- (2011) Francesco Peri et al. BIOTECHNOLOGY ADVANCES
- Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye
- (2008) Saadia Rashid ARCHIVES OF OPHTHALMOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started